The second step was the immunohistochemical assessment for expression of cellular proteins that are acquired (Gal3, HBME1, CK19) or lost (CD56) during neoplastic transformation in thyroid oncogenesis. This evidence concerns the gene NCAM1 and thyroid gland disorder.